Table 1. Clinical and laboratory findings of HCWs in whom Crimean-Congo hemorrhagic fever developed after occupational exposure, Turkey, 2004–2011*†.
| HCW, outcome | Body temperature, °C | Bleeding | Leukocytes/mm3 | Platelets/mm3 | AST | ALT | APTT | Fibrinogen | SSI |
|---|---|---|---|---|---|---|---|---|---|
| 1, survived | 38.5 | No | 800 | 42,000 | 425 | 346 | 44 | 225 | Moderate |
| 2, survived | 37.2 | No | 1100 | 53,000 | 145 | 81 | 43 | 270 | Mild |
| 3, died | 40.5 | Ecchymosis, hematemesis, melena, hematuria | 11,100 | 40,000 | 251 | 277 | 90 | 171 | Severe |
| 4, survived | 40.5 | No | 2,900 | 78,000 | 150 | 110 | 37.4 | 250 | Mild |
| 5, survived | 39 | Epistaxis | 1,800 | 58,000 | 167 | 129 | 64 | 218 | Moderate |
| 6, survived | 40.5 | No | 1,800 | 44,000 | 123 | 216 | 40.5 | 165 | Moderate |
| 7, survived | 39.1 | No | 3,100 | 13,000 | 418 | 132 | 40.9 | 170 | Moderate |
*HCW, health care worker; AST, aspartate aminotransferase; ALT, alanine aminotransferase; APTT, activated partial thromboplastin time ; SSI, severity score index. †Reference values: leukocytes, 4,000–11,000/mm3; platelets, 150,000–450,000/mm3; AST, <50 IU/L; ALT, <50 IU/L; APTT, 24–36 sec; fibrinogen, 200–400 mg/dL.